Jolanta M. Durski, M.D.

  1. Nuclear Medicine Specialist
  1. Bogsrud TV, Engelsen O, Lu TTT, Stensvold A, Johnson DR, Burkett BJ, Kendi AT, Pandey MK, Sundset R, Durski JM. All that glitters is not gold: high uptake on PSMA PET in non-prostate cancers does not mean that treatment with [(177)Lu]Lu-PSMA-radioligand will be successful. EJNMMI Res. 2024 Oct 15; 14 (1):95
    View PubMed
  2. Frota Lima LM, Bogsrud TV, Gharib H, Ryder M, Johnson G, Durski J. Risk of malignancy in thyroid nodules with increased 11C-Choline uptake detected incidentally on PET/CT: A diagnostic accuracy study. Medicine (Baltimore). 2024 Sep 6; 103 (36):e39602
    View PubMed
  3. Toro-Tobon D, Morris JC, Hilger C, Peskey C, Durski JM, Ryder M. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers. Thyroid. 2024 Jan; 34 (1):70-81 Epub 2023 Dec 12
    View PubMed
  4. Bogsrud T, Jacobsen M, Durski J, Larsen E, Engelsen O, Haskjold OI, Castillejo M, Bach-Gansmo T, Nostrand DV. Letter to the Editor: Repeat Redifferentiation of Radioiodine Refractory BRAF(V600E) Mutated Thyroid Cancer with Dabrafenib. Thyroid 2023 Jun; 33 (6):771-773 Epub 2023 May 30
    View PubMed
  5. Durski JM, Hruska CB, Bogsrud TV, Ryder M, Johnson GB. 123I Scan With Whole-Body Retention Measurement at 48 Hours for Simplified Dosimetry Before 131I Treatment of Metastatic Thyroid Cancer. Clin Nucl Med. 2021 Mar 1; 46 (3):e151-e153
    View PubMed
  6. Parvinian A, Martin-Macintosh EL, Goenka AH, Durski JM, Mullan BP, Kemp BJ, Johnson GB. (11)C-Choline PET/CT for Detection and Localization of Parathyroid Adenomas. AJR Am J Roentgenol. 2018 Feb; 210 (2):418-422 Epub 2017 Nov 15
    View PubMed
  7. Merten MM, Castro MR, Zhang J, Durski J, Ryder M. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules. Thyroid. 2017 Jan; 27 (1):95-102 Epub 2016 Dec 05
    View PubMed
  8. Stan MN, Durski JM, Brito JP, Bhagra S, Thapa P, Bahn RS. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment. Thyroid. 2013 May; 23 (5):620-5
    View PubMed
  9. Cheville AL, Brinkmann DH, Ward SB, Durski J, Laack NN, Yan E, Schomberg PJ, Garces YI, Suman VJ, Petersen IA. The addition of SPECT/CT lymphoscintigraphy to breast cancer radiation planning spares lymph nodes critical for arm drainage. Int J Radiat Oncol Biol Phys. 2013 Mar 15; 85: (4)971-7.
    View PubMed
  10. Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010 Jul; 75(1):e68-73. Epub 2009 Aug 27.
    View PubMed
  11. Summers HG, Loftus EV Jr, Sebo TJ, Durski JM. Appendiceal carcinoid mimicking a Meckel's diverticulum on Tc-99m pertechnetate imaging. Clin Nucl Med. 2010 Apr; 35: (4)277-9.
    View PubMed
  12. Karantanis D, Durski JM, Lowe VJ, Nathan MA, Mullan BP, Georgiou E, Johnston PB, Wiseman GA. 18 F-FDG PET and PET/CT in Burkitt's lymphoma. Eur J Radiol. 2010; 75(1):e68-e73.
  13. Karantanis D, Subramaniam RM, Peller PJ, Lowe VJ, Durski JM, Collins DA, Georgiou E, Ansell SM, Wiseman GA. The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma. Clin Lymphoma Myeloma. 2008 Apr; 8: (2)94-9.
    View PubMed
  14. Meyers A, Durski JM, Snow AA. Nuclear medicine gastrointestinal bleeding examination utilizing an UltraTag kit reveals unusual bone marrow and hepatic uptake: a case study report. JNMT. 2004; 32(1):16-8.
  15. Durski JM. Young patient with wrist pain - Continuing Medical Education. Nuclear Medicine Review - Central and Eastern Europe. 2002; 5(1):67-8.
    View PubMed
  16. Durski JM, Twist CJ, Goris M. A case from Stanford University. Neuroblastoma with diffuse bone marrow involvement. Nucl Med Rev Cent East Eur. 2001; 4(1):61-2.
    View PubMed
  17. Durski JM, Srinivas S, Segall G. Comparison of FDG-PET and bone scans for detecting skeletal metastases in patients with non-small cell lung cancer. Clinical Positron Imaging. 2000; 3(3):97-105.
    View PubMed
  18. Durski JM, Weigel RJ, McDougall IR. Recombinant human thyrotropin (rh TSH) in the management of differentiated thyroid cancer. Nuclear Medicine Communications. 2000; 21(6):521-8.
    View PubMed
  19. Conti PS, Durski JM, Bacquai F, Grafton ST, Singer PA. Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid. 1999; 9(8):797-804.
    View PubMed
  20. Bialobrzeska B, Bialobrzeski J, Liniecki J, Wdowczyk J. Stability of 99mTc-Mebrofenin and 99mTc-HEPIDA in human blood. Probl Med Nukl. 1993; 7(14):141-147.